JP2013510182A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013510182A5 JP2013510182A5 JP2012538087A JP2012538087A JP2013510182A5 JP 2013510182 A5 JP2013510182 A5 JP 2013510182A5 JP 2012538087 A JP2012538087 A JP 2012538087A JP 2012538087 A JP2012538087 A JP 2012538087A JP 2013510182 A5 JP2013510182 A5 JP 2013510182A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- item
- pharmaceutically acceptable
- xaa
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25926409P | 2009-11-09 | 2009-11-09 | |
| US61/259,264 | 2009-11-09 | ||
| PCT/US2010/056042 WO2011057272A1 (en) | 2009-11-09 | 2010-11-09 | Treatments for gastrointestinal disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013510182A JP2013510182A (ja) | 2013-03-21 |
| JP2013510182A5 true JP2013510182A5 (enExample) | 2016-01-28 |
| JP5913115B2 JP5913115B2 (ja) | 2016-05-11 |
Family
ID=43503086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012538087A Expired - Fee Related JP5913115B2 (ja) | 2009-11-09 | 2010-11-09 | 胃腸障害のための処置 |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US20140179607A9 (enExample) |
| EP (1) | EP2499154B1 (enExample) |
| JP (1) | JP5913115B2 (enExample) |
| KR (1) | KR20120115495A (enExample) |
| CN (1) | CN102812038B (enExample) |
| AR (1) | AR078950A1 (enExample) |
| AU (1) | AU2010314866B2 (enExample) |
| BR (1) | BR112012011730A2 (enExample) |
| CA (1) | CA2779482A1 (enExample) |
| CL (1) | CL2012001186A1 (enExample) |
| CO (1) | CO6551683A2 (enExample) |
| CR (1) | CR20120303A (enExample) |
| EA (1) | EA022817B1 (enExample) |
| EC (1) | ECSP12011962A (enExample) |
| ES (1) | ES2620153T3 (enExample) |
| GE (1) | GEP20166435B (enExample) |
| IL (1) | IL219596A0 (enExample) |
| MX (2) | MX350046B (enExample) |
| NZ (1) | NZ599751A (enExample) |
| PH (1) | PH12012500916B1 (enExample) |
| SG (1) | SG10201407403UA (enExample) |
| TW (1) | TWI482626B (enExample) |
| UA (1) | UA114274C2 (enExample) |
| UY (2) | UY33017A (enExample) |
| WO (1) | WO2011057272A1 (enExample) |
| ZA (1) | ZA201203342B (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2009013293A (es) | 2007-06-04 | 2010-02-15 | Synergy Pharmaceuticals Inc | Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos. |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| EP2810951B1 (en) | 2008-06-04 | 2017-03-15 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| CA2730603C (en) | 2008-07-16 | 2019-09-24 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| EP2370087A4 (en) * | 2008-12-02 | 2013-08-28 | Ironwood Pharmaceuticals Inc | METHOD AND COMPOSITIONS FOR THE TREATMENT OF LIQUID RETENTION DISEASES |
| PH12012500916B1 (en) | 2009-11-09 | 2018-03-23 | Ironwood Pharmaceuticals Inc | Treatments for gastrointestinal disorders |
| EP2509992B1 (en) * | 2009-12-07 | 2015-10-14 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
| US9650417B2 (en) | 2011-05-11 | 2017-05-16 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
| WO2012155108A1 (en) * | 2011-05-11 | 2012-11-15 | Ironwood Pharmaceuticals, Inc. | Treatments for disorders using guanylate cyclase c agonists |
| WO2012155114A1 (en) | 2011-05-11 | 2012-11-15 | Ironwood Pharmaceuticals, Inc. | Peptides derived from uroguanylin and their use in gastrointestinal disorders |
| US9617305B2 (en) | 2011-06-08 | 2017-04-11 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
| US9527887B2 (en) | 2011-06-08 | 2016-12-27 | Ironwood Pharmaceutical, Inc. | Treatments for gastrointestinal disorders |
| HUE032237T2 (en) * | 2011-08-17 | 2017-09-28 | Ironwood Pharmaceuticals Inc | Treatments for gastrointestinal disorders |
| WO2014088623A1 (en) * | 2012-07-12 | 2014-06-12 | Forest Laboratories Holdings Limited | Linaclotide compositions |
| JP2016514671A (ja) | 2013-03-15 | 2016-05-23 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼのアゴニストおよびその使用 |
| KR20160042039A (ko) | 2013-08-09 | 2016-04-18 | 알데릭스, 인코포레이티드 | 인산염 수송을 억제하기 위한 화합물 및 방법 |
| AU2014331812B2 (en) * | 2013-10-09 | 2019-01-17 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for downregulation of pro-inflammatory cytokines |
| WO2016015055A1 (en) * | 2014-07-25 | 2016-01-28 | Ironwood Pharmaceuticals, Inc. | Colon cleansing compositions |
| WO2020237096A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Combination for lowering serum phosphate in a patient |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB290795A (en) | 1927-04-08 | 1928-05-24 | British Colour Printing Compan | Improvements in or relating to advertising or display devices |
| US5879656A (en) | 1993-10-26 | 1999-03-09 | Thomas Jefferson University | Methods of treating metastatic colorectal cancer with ST receptor binding compounds |
| ES2216004T3 (es) | 1993-10-26 | 2004-10-16 | Thomas Jefferson University | Composiciones que se unen especificamente a celulas cancerosas colorectales y procedimientos de uso de las mismas. |
| US5518888A (en) | 1993-10-26 | 1996-05-21 | Thomas Jefferson University | ST receptor binding compounds and methods of using the same |
| US5962220A (en) | 1993-10-26 | 1999-10-05 | Thomas Jefferson University | Compositions that specifically bind to colorectal cells and methods of using the same |
| US5601990A (en) | 1994-09-13 | 1997-02-11 | Thomas Jefferson University | Methods of diagnosing colorectal tumors and metastasis thereof |
| CH689139A5 (de) | 1995-04-03 | 1998-10-30 | Cerbios Pharma Sa | Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung. |
| US5912014A (en) | 1996-03-15 | 1999-06-15 | Unigene Laboratories, Inc. | Oral salmon calcitonin pharmaceutical products |
| AU2001256315A1 (en) * | 2000-04-22 | 2001-11-07 | Ipf Pharmaceuticals Gmbh | Use of guanylate cyclase-c (gc-c) agonists as insulinotropic factors for treating diabetes type 2 |
| US7304036B2 (en) | 2003-01-28 | 2007-12-04 | Microbia, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| US7772188B2 (en) * | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| US7371727B2 (en) | 2003-01-28 | 2008-05-13 | Microbia, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| ATE477268T1 (de) | 2003-01-28 | 2010-08-15 | Ironwood Pharmaceuticals Inc | Zusammensetzungen zur behandlung von magen-darm- störungen |
| WO2007022531A2 (en) | 2005-08-19 | 2007-02-22 | Microbia, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| MX2009013293A (es) * | 2007-06-04 | 2010-02-15 | Synergy Pharmaceuticals Inc | Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos. |
| US20120213846A1 (en) | 2008-08-15 | 2012-08-23 | Forest Laboratories Holdings Limited | Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration |
| US20120039949A1 (en) | 2008-09-04 | 2012-02-16 | Ironwood Pharmaceuticals, Inc. | Stable Solid Formulations of GC-C Receptor Agonist Polypeptides Suitable for Oral Administration |
| PH12012500916B1 (en) * | 2009-11-09 | 2018-03-23 | Ironwood Pharmaceuticals Inc | Treatments for gastrointestinal disorders |
| WO2011156453A2 (en) | 2010-06-09 | 2011-12-15 | Combimab, Inc. | Therapeutic peptides |
-
2010
- 2010-11-09 PH PH1/2012/500916A patent/PH12012500916B1/en unknown
- 2010-11-09 EP EP10782095.3A patent/EP2499154B1/en active Active
- 2010-11-09 JP JP2012538087A patent/JP5913115B2/ja not_active Expired - Fee Related
- 2010-11-09 CA CA2779482A patent/CA2779482A1/en not_active Abandoned
- 2010-11-09 WO PCT/US2010/056042 patent/WO2011057272A1/en not_active Ceased
- 2010-11-09 UY UY0001033017A patent/UY33017A/es not_active Application Discontinuation
- 2010-11-09 AU AU2010314866A patent/AU2010314866B2/en not_active Ceased
- 2010-11-09 UA UAA201206987A patent/UA114274C2/uk unknown
- 2010-11-09 MX MX2014016035A patent/MX350046B/es unknown
- 2010-11-09 TW TW099138547A patent/TWI482626B/zh not_active IP Right Cessation
- 2010-11-09 ES ES10782095.3T patent/ES2620153T3/es active Active
- 2010-11-09 CN CN201080060997.XA patent/CN102812038B/zh not_active Expired - Fee Related
- 2010-11-09 SG SG10201407403UA patent/SG10201407403UA/en unknown
- 2010-11-09 GE GEAP201012738A patent/GEP20166435B/en unknown
- 2010-11-09 UY UY0001033018A patent/UY33018A/es not_active Application Discontinuation
- 2010-11-09 NZ NZ599751A patent/NZ599751A/en not_active IP Right Cessation
- 2010-11-09 BR BR112012011730A patent/BR112012011730A2/pt not_active IP Right Cessation
- 2010-11-09 KR KR1020127014811A patent/KR20120115495A/ko not_active Abandoned
- 2010-11-09 US US13/508,843 patent/US20140179607A9/en not_active Abandoned
- 2010-11-09 AR ARP100104153A patent/AR078950A1/es unknown
- 2010-11-09 MX MX2012005368A patent/MX2012005368A/es active IP Right Grant
- 2010-11-09 EA EA201290322A patent/EA022817B1/ru not_active IP Right Cessation
- 2010-11-09 US US12/942,887 patent/US8507447B2/en active Active
-
2012
- 2012-05-03 IL IL219596A patent/IL219596A0/en unknown
- 2012-05-07 CL CL2012001186A patent/CL2012001186A1/es unknown
- 2012-05-07 ZA ZA2012/03342A patent/ZA201203342B/en unknown
- 2012-05-16 CO CO12081055A patent/CO6551683A2/es active IP Right Grant
- 2012-06-06 CR CR20120303A patent/CR20120303A/es unknown
- 2012-06-08 EC ECSP12011962 patent/ECSP12011962A/es unknown
-
2013
- 2013-03-14 US US13/830,656 patent/US8946158B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013512960A5 (enExample) | ||
| TWI482626B (zh) | 胃腸道病症的治療 | |
| US20220233635A1 (en) | Stable Formulations of Linaclotide | |
| RU2012128509A (ru) | Способы лечения заболеваний желудочно-кишечного тракта | |
| US20110059903A1 (en) | Formulations Comprising Linaclotide | |
| CA2846230A1 (en) | Treatments for gastrointestinal disorders | |
| JP2025169325A (ja) | 結腸洗浄及び胃腸障害の治療のための組成物 | |
| US20150030697A1 (en) | Treatments for gastrointestinal disorders | |
| US9303066B2 (en) | Treatments for gastrointestinal disorders | |
| WO2015054649A2 (en) | Agonists of guanylate cyclase useful for the treatment of opioid induced dysfunctions | |
| WO2012170766A1 (en) | Treatments for gastrointestinal disorders | |
| HRP20200188T1 (hr) | Višeslojna tableta za davanje magnezija | |
| TH145794A (th) | สารบำบัดสำหรับความผิดปกติของโรคกระเพาะอาหารและลำไส้ (Gastrointestinal Disorders) | |
| HK40097176A (en) | Compositions for colon cleansing and the treatment of gastrointestnal disorders | |
| HK1178919A (en) | Treatments for gastrointestinal disorders | |
| HK1178919B (en) | Treatments for gastrointestinal disorders |